Literature DB >> 18926291

Recent advances in the genetic analysis of PTEN and PI3K innate immune properties.

Philipp Günzl1, Gernot Schabbauer.   

Abstract

The role of the PI3-kinase pathway and its antagonist PTEN in the regulation of innate immune responses has only recently attracted the attention of the scientific community. The PI3K/PTEN signaling axis is most renowned for its critical involvement in the malignant transformation of cells leading to tumorigenesis. PI3K function in the regulation of innate immunity, either pro-inflammatory or anti-inflammatory, is still a controversial issue. Undoubtedly, PI3K serves as an essential pro-inflammatory signaling molecule to activate leukocytes, initiate migration and facilitate phagocytosis. Nevertheless, it is less clear how PI3K and PTEN modulate the amplitude of immune responses. Here, we review recent advances on the immune biology by means of reverse genetics analyzing the role of the PI3K/PTEN signaling cascade in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926291     DOI: 10.1016/j.imbio.2008.07.028

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  21 in total

1.  The p110δ subunit of PI3K regulates bone marrow-derived eosinophil trafficking and airway eosinophilia in allergen-challenged mice.

Authors:  Bit Na Kang; Sung Gil Ha; Xiao Na Ge; M Reza Hosseinkhani; Nooshin S Bahaie; Yana Greenberg; Malcolm N Blumenthal; Kamal D Puri; Savita P Rao; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

2.  PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.

Authors:  Naoko Kamo; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2012-12-04       Impact factor: 17.425

3.  Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation.

Authors:  Amitava Das; Kasturi Ganesh; Savita Khanna; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

4.  The tumor suppressor PTEN has a critical role in antiviral innate immunity.

Authors:  Shun Li; Mingzhu Zhu; Ruangang Pan; Ting Fang; Yuan-Yuan Cao; Shuliang Chen; Xiaolu Zhao; Cao-Qi Lei; Lin Guo; Yu Chen; Chun-Mei Li; Eija Jokitalo; Yuxin Yin; Hong-Bing Shu; Deyin Guo
Journal:  Nat Immunol       Date:  2015-12-21       Impact factor: 25.606

5.  MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity.

Authors:  Thomas X Lu; Jochen Hartner; Eun-Jin Lim; Victoria Fabry; Melissa K Mingler; Eric T Cole; Stuart H Orkin; Bruce J Aronow; Marc E Rothenberg
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

Review 6.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

7.  AS252424, a PI3Kγ inhibitor, downregulates inflammatory responsiveness in mouse bone marrow-derived mast cells.

Authors:  Meihua Jin; Qianxiang Zhou; Eunkyung Lee; Shingo Dan; Hong Quan Duan; Dexin Kong
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

8.  Suppression of host PTEN gene expression for Leishmania donovani survival in Indian visceral leishmaniasis.

Authors:  Medhavi Sudarshan; Toolika Singh; Bhawana Singh; Jaya Chakravarty; Shyam Sundar
Journal:  Microbes Infect       Date:  2016-01-14       Impact factor: 2.700

9.  Similarities in features of autism and asthma and a possible link to acetaminophen use.

Authors:  Kevin G Becker; Stephen T Schultz
Journal:  Med Hypotheses       Date:  2009-09-11       Impact factor: 1.538

10.  Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans.

Authors:  Hong Yu; Michael Valerio; Jacek Bielawski
Journal:  J Lipid Res       Date:  2012-11-08       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.